Aurobindo Pharma has announced a significant interim dividend of 400%, translating to ₹4.00 per equity share of face value ₹1 each. The decision was approved during the Board of Directors meeting held on August 4, 2025.
The company has fixed August 8, 2025, as the record date to determine shareholders eligible for the dividend. Payment is scheduled to be made on or before August 21, 2025.
In the exchange filings, the company shared, “The Board of Directors of the Company at its meeting held today, August 4, 2025, has approved the payment of interim dividend of 400% i.e. Rs.4.00 (Rupee Four only) per equity share of Re.1/- each on the equity share capital of the Company. The Company has fixed August 8, 2025, as the Record Date for the purpose of payment of Interim Dividend and the same will be paid on or before August 21, 2025.”
The board meeting, which began at 4:30 p.m., concluded at 5:50 p.m. This interim payout underscores Aurobindo Pharma’s strong financial position and shareholder-focused approach.
